CoChat
Cited by 113

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Precocious Puberty: Who Has It? Who Should Be Treated?

Oerter Klein, Karen · 1999 · The Journal of Clinical Endocrinology & Metabolism

Abstract

In this issue of JCEM, Palmert et al. (see page 415) (1), address the issue of whether all children with precocious puberty need treatment by reporting long-term follow-up data on 20 girls with unsustained or slowly progressive early puberty. This group of girls on the average achieved their genetic height potential and normal adult heights without treatment. Ten of the 20 girls had onset of puberty after 5 yr of age. Thirteen of the 20 girls had a bone age (BA) advance greater than 2 yr above chronological age (CA). None of the girls had GnRH-stimulated peak LH levels over 25 IU/L, and all had a GnRH-stimulated FSH peak greater than the LH peak. Unsustained precocious puberty was defined as no further pubertal development or regression of development as determined by a questionnaire. Slowly progressive puberty was also defined by questionnaire. This study once again demonstrates that not all girls with precocious puberty need treatment, and it raises these questions: What is precocious puberty? Who has precocious puberty? Which children should be treated? Precocious puberty has most commonly been defined as the onset of puberty before the age of 8 yr in girls and before the age of 9 yr in boys. It involves not only early physical changes of puberty, but also linear growth acceleration and acceleration of bone maturation, which leads to early epiphyseal fusion and short adult height. Precocious puberty can be true or GnRH-dependent puberty, or it can be peripheral or GnRH-independent puberty. The questions raised by Palmert et al relate only to children with possible idiopathic true precocious puberty. Most girls (95%) with precocious puberty have idiopathic true precocious puberty. Boys more commonly (>50%) have an identifiable etiology for precocious puberty. The causes of true precocious puberty include central nervous system lesions, secondary to GnRH-independent precocious puberty, and idiopathic precocious puberty. The causes of GnRH-independent puberty include gonadal, adrenal, ectopic, or exogenous sources of hormone production. Adrenal causes include congenital adrenal hyperplasia (CAH) and tumors. Gonadal causes include McCune-Albright syndrome, familiar male precocious puberty, and tumors. Ectopic causes include human chorionic gonadotropin secreting tumors. Hypothyroidism may also cause GnRH-independent precocious puberty. True precocious puberty involves activation of the hypothalamic-pituitary-gonadal axis (HPGA). Standard treatment of precocious puberty involves suppression of this axis with GnRH agonists (2). When precocious puberty is not idiopathic, treatment is based first on treating the underlying problem, and then may also involve treatment with GnRH agonists. For example, children with non-salt wasting CAH may present with precocious puberty. Appropriate management of CAH is initiated first, followed by further evaluation of the need for GnRH agonist therapy. A more detailed discussion of nonidiopathic precocious puberty is beyond the scope of this editorial. The remainder of this discussion relates to idiopathic precocious puberty. Knowing why we treat idiopathic precocious puberty is integral to understanding the questions of whom should we treat. The only long-term complication of true idiopathic precocious puberty is compromised adult height. Adult height is improved with treatment (2, 3). Therefore, part of the decision of who to treat involves estimating adult height based on the child’s current height and bone age, and comparing this predicted height with mid-parental height (MPH) and with the normal population. The other reasons to treat are psychosocial or behavioral. For example, a 4-yr-old with menses, even if she has a good predicted height, may deserve treatment. Or the 7-yr-old who is behind in school may deserve treatment so that she is not so far ahead of her peers and experiencing emotions related to hormonal changes that she cannot understand. The age definition of normal pubertal development is based on 95% of the population or 2 standard deviations (sd) below the mean age of pubertal onset in normal girls. Hence 2.5% of normal girls have onset of puberty before age 8. When puberty in girls begins between 6 and 8 yr, is it truly precocious puberty or simply at the outer limits of normal? Are there some girls for whom earlier onset is normal and others for whom it is precocious? Herman-Giddens et al. (4) have recently studied 17,077 girls and reported normal onset of puberty to be earlier than previously thought. In their population the mean age of breast development in African-American girls was 8.87 ± 1.93 yr (mean ± sd) and in white girls was 9.96 ± 1.82 yr. If the definition of precocious is 2 sd below the mean, then, based on this data, precocious puberty would be defined as onset less than 5 yr in African-American girls and onset less than 6.3 yr in white girls. However, this study did not have endocrine evaluations or follow-up data to determine if any of the

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem.84.2.5533

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Oerter Klein, K.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1999-02-01
Volume
84
Issue
2
Pages
411-414
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2132719252
Cited by
113
References
1
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.